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Abstract
Circadian rhythms in cardiac function are apparent in e.g., blood pressure, heart rate, and acute adverse cardiac events. A
circadian clock in heart tissue has been identified, but entrainment pathways of this clock are still unclear. We cultured
tissues of mice carrying bioluminescence reporters of the core clock genes, period 1 or 2 (per1luc or PER2LUC) and compared
in vitro responses of atrium to treatment with medium and a synthetic glucocorticoid (dexamethasone [DEX]) to that of the
suprachiasmatic nucleus (SCN) and liver. We observed that PER2LUC, but not per1luc is rhythmic in atrial tissue, while both
per1luc and PER2LUC exhibit rhythmicity in other cultured tissues. In contrast to the SCN and liver, both per1luc and PER2LUC
bioluminescence amplitudes were increased in response to DEX treatment, and the PER2LUC amplitude response was
dependent on the time of treatment. Large phase-shift responses to both medium and DEX treatments were observed in
the atrium, and phase responses to medium treatment were not attributed to serum content but the treatment procedure
itself. The phase-response curves of atrium to both DEX and medium treatments were found to be different to the liver.
Moreover, the time of day of the culturing procedure itself influenced the phase of the circadian clock in each of the
cultured tissues, but the magnitude of this response was uniquely large in atrial tissue. The current data describe novel
entrainment signals for the atrial circadian clock and specifically highlight entrainment by mechanical treatment, an
intriguing observation considering the mechanical nature of cardiac tissue.
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Introduction
In mammals, many processes in physiology show daily variation
under normal conditions. When these daily patterns persist under
constant conditions, they are described as circadian (, 24 hours)
rhythms, and are driven by an endogenous clock. Circadian
rhythms are governed by internal clocks that, in the presence of
timing cues, are synchronized (entrained) to the external
environment [1]. The central light-entrainable clock resides in
the suprachiasmatic nucleus (SCN) of the hypothalamus, and the
SCN transmits timing information in a hierarchical manner to
clocks found in peripheral tissues [2]. Temporal orchestration of
cellular processes is seen in many peripheral tissues, such as in the
liver and cardiovascular tissue, and it is thought that these tissues
use a similar molecular clock mechanism as described for the
SCN.
For the heart, diel (observed under light:dark conditions) and
circadian rhythms are apparent in physiology and behavior. Peaks
in both arterial blood pressure and heart rate in mice are observed
when they are active, around Zeitgeber time 15 (ZT; ZT 0= lights
on, ZT 12= lights off) and at ZT 12, respectively [3]. While
behavioral state is an important causal factor to diurnal variation
in blood pressure and heart rate, there is a significant contribution
of a functional circadian clock to this rhythm [4]. A temporal
profile with an early morning peak in acute adverse cardiac events
and sudden cardiac death is observed in man [5,6] and cardiac
vulnerability has been found to have a circadian component that is
independent of behavior [7]. Interestingly, tau mutant hamsters,
that exhibit significantly reduced intrinsic day-length, show
significant cardiac hypotrophy, reduced blood pressure and
impaired myocardial contractility [8]. Also, mice that have a
functional knockout of the gene encoding vasoactive intestinal
polypeptide, a major SCN neuropeptide, show dampened rhythms
in heart rate under entrained conditions and loss of this rhythm
under constant darkness conditions [9].
A defining characteristic of circadian clocks is the expression of
canonical clock genes (e.g. clock, bmal1, per and cry genes) which,
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through regulatory feedback loops, orchestrate each other’s
activity, resulting in rhythmically active transcriptional loops
[10]. Cardiac tissue has been shown to exhibit rhythmic gene
expression, including the expression of canonical clock genes, in
vivo both in the presence of an entraining light-dark (LD) cycle and
under constant conditions [11–14]. In vitro cultures of cardiac
tissue also show robust rhythmic expression of per1 as reported by
bioluminescence, indicating a functional circadian clock in the
heart [15,16]. Circadian variation in cardiac function persists in
isolated heart tissue, highlighting the cell-autonomous activity of
the cardiac clock. For example, rat hearts in vitro exhibit 24 hr
variation in contractile responses, oxidative metabolism, oxidative
stress tolerance and lipid peroxidation, and rhythmic electro-
chemical activity is maintained in isolated myocytes [17,18].
Disruption of the circadian clock in the heart results in decreased
diurnal variations in heart rate, sinus bradycardia, loss of diurnal
variations in cardiac power and responsiveness of the heart to
changes in workload, increased fatty acid oxidation, decreased
cardiac efficiency, as well as other cellular functions [19].
Clocks in peripheral tissues are entrained in part, by the central
light entrainable clock in the SCN, and there are factors in serum
that can reset peripheral clocks such as in liver and fibroblasts cells
[20–23]. Glucocortcoids (GCs) have been implicated as being
important in synchronizing clocks in peripheral tissues in vivo and
in vitro [24]. Indeed, there is evidence for direct binding of the
glucocorticoid receptor (GR) to per1 and per2 genes, and binding of
the GR to per2 is essential for amplitude regulation by the synthetic
glucocorticoid dexamethasone (DEX) in in vitro cultures of
mesenchymal stem cells, and maybe even for the maintenance
of a peripheral rhythm per se [13,25]. In response to acute stress,
per1 mRNA, but not per2 mRNA is readily upregulated in the
heart, and this is subject to the presence of the GR binding
sequence in the promoter region of the per1 gene [13].
GCs are steroid hormones that are released by the adrenal
gland. The release of GCs is under the control of the
hypothalamic-pituitary-adrenal (HPA) axis and GCs show a daily
rhythm in circulating plasma levels. Plasma levels of corticoste-
rone, a major GC, peak at the onset of activity, both in nocturnal
and diurnal subjects. As the main light-entrained circadian
oscillator, the SCN drives rhythms in plasma GCs, and when
the SCN is lesioned, the daily rhythm in circulating corticosterone
is ablated [26]. The SCN acts on the adrenal gland, both through
direct sympathetic connections to the adrenal cortex, and through
modulating adrenocorticotropic hormone (ACTH) release via
rhythmic release of corticotrophin-releasing hormone from the
hypothalamic paraventricular nucleus (For review see [27]). The
sympathetic SCN-adrenal pathway is hypothesized to control the
adrenal sensitivity to circulating ACTH [28]. Besides SCN control
of daily rhythms in GCs levels, there is also a role of clocks in the
adrenal gland itself.
Most canonical clock genes show rhythmic expression in the
adrenal gland and the adrenal clock regulates the sensitivity of the
adrenal gland to ACTH, varying with time-of-day [29]. Moreover,
the local adrenal clock has been reported to cause rhythmic
expression of adrenal steroid production, and absence of the
adrenal clock reduces daily amplitude of steroid production [30].
This reduced amplitude could be indicative of a role of GCs in
synchronizing clocks in peripheral tissues [24], where desynchro-
nized tissue cause an attenuation of overall amplitude of the clock
and clock output.
Circadian rhythms are apparent in cardiac tissue at the
molecular and functional level. It has been shown previously that
DEX can affect clock gene expression in the heart [24], although
this has been tested only at one particular time of day. Because of
the reported susceptibility of clock genes to GCs, we set out to
study the response of atrial tissue to dexamethasone (DEX) in a
time informed manner. Using in vitro atrial tissue cultures of mice
carrying bioluminescence reporters for per1 and PER2 activity, we
monitored the circadian clock in this tissue, and it’s response to
DEX treatment. In vitro culture systems allow for true examination
of tissue-specific circadian responses independent of extrinsic
systemic factors. In these studies we specifically focused on the
cardiac atria. The cardiac atria are multifaceted structures that
function in the circulatory system to promote continuous venous
flow; they contain pacemaker elements required for timing of heart
rate; and function as an endocrine organ, producing atrial
natriuretic peptide in response to stretching of the atrial vessel
walls associated with elevated blood pressure or volume [31,32].
Because DEX reportedly does not shift the rhythm of per1
expression in the SCN (although only tested at one time of day),
but has a known response in liver [24], we also cultured SCN and
liver of the same individuals.
Results
The peak phase of the circadian rhythm of in vitro biolumines-
cence shows variation as a result of the time of sacrifice and
subsequent culturing. Figure 1 shows that in cultures of the SCN,
liver and especially atrial tissues the phase of the first PER2LUC
driven peak in vitro is different between groups with different times
of killing and culturing (One way ANOVA; SCN, F3,26 = 18.442;
liver, F3,74 = 5.384; atria, F3,101 = 499.783; P’s ,0.002 for culture
start time). In the case of atrial tissue, the peak phase of PER2LUC
bioluminescence rhythm is actually different between each of the
four culture start times. In order to test for a possible ‘resetting’ of
the clock, the time interval between start of culturing and the first
peak was calculated, and shown to be different for different times
of sacrifice for each of the tissues (Kruskal–Wallis one-way
ANOVA; SCN, H3= 16.002; liver, H3= 56.333; atria,
H3= 70.306; P’s ,0.001 for cultures start time). These data
indicate that an in vivo treatment followed by in vitro culturing at
different times of day is not a suitable approach for testing the
effects of DEX on atrial or other tissues in a time-informed
manner, we therefore continued with an in vitro treatment
approach, where time of treatment is determined by the phase
of bioluminescence after culturing.
Using this in vitro approach we first cultured tissues and then
subjected them to control or experimental conditions. Represen-
tative baseline subtracted traces for per1 and PER2 driven
bioluminescence are shown in Figure 2A and 2B respectively.
Traces are shown for SCN, liver and atrial cultures that received
no treatment, or were treated with medium or DEX. As a first
observation, no rhythms in per1luc bioluminescence were detectable
in the atria. In contrast, PER2LUC bioluminescence was rhythmic
in all tissues. This observation is quantified in Table 1, which
indicates the significant lack of rhythmic cultures of per1luc
bioluminescence as compared to PER2LUC bioluminescence
(chi-square, x1 = 134.111, P,0.001). The fraction of cultures that
showed rhythmicity was 97% for the SCN and 82% for liver
cultures and was not different between per1 and PER2 driven
bioluminescence (chi-square, x1 = 1.525 and x1 = 0.486 respec-
tively, P’s .0.05).
As a first response to treatment, we quantified the change in the
amplitude of the oscillation in bioluminescence in response to no
treatment, and medium or DEX treatment. DEX treatment
increased the amplitude of the per1luc bioluminescence oscillation
in cultures of liver, but not SCN (two way ANOVA, effect of tissue
F1,23 = 35.208; effect of treatment F2,23 = 21.292; interaction effect
Atrial Circadian Rhythms in Mice In Vitro
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F2,23 = 16.071, P’s ,0.001), an amplitude increase in atrium is
apparent, but could not be quantified due to absence of a rhythm
before treatment (Figure S1). Although already slightly increased
in response to medium treatment, DEX treatment resulted in a 4-
fold increase in amplitude, which was not dependent on time of
treatment (Holm-Sidak; P.0.05; data not shown). The amplitude
increase for atrial tissue in response to DEX was not quantifiable
due to a lack of pre-treatment rhythmicity. Because of the lack of
oscillations in atrial per1luc bioluminescence, we continued to look
at PER2LUC bioluminescence. Figure 2C shows amplitude
responses in PER2LUC bioluminescence in SCN, liver and atrial
cultures, where only in atrial tissue a significant increase in
amplitude was observed (two way ANOVA, effect of tissue
F2,200 = 8.235, P,0.001; effect of treatment F2,200 = 5.858,
P,0.005; interaction effect F4,200 = 11.725, P,0.001). The post
hoc contrasts indicated that the only significant change in post-
treatment amplitude is observed in the atrium after DEX
treatment (Holm-Sidak; P,0.001 for DEX versus no treatment
and medium treated). Interestingly, while there is an overall .3-
fold increase in amplitude, the response of the atrium to DEX is
time dependant, in contrast to the medium treatment (Figure 2D;
PROC mixed: effect of treatment, F1,51 = 47.78, P,0.0001; effect
of time, F21,51 = 2.04, P,0.05; interaction effect, F19,51 = 1.79,
P = 0.05), where DEX treatment shows a significant increase
versus medium treatment when treated 2, 3, 5, 6, 9 & 10 hours
after the last peak in bioluminescence. While there were already
no significant increases in overall amplitude responses in liver and
SCN, testing for differential treatment, time-of-day, or interaction
effect for either SCN or liver tissue, revealed no significant effects
(P’s .0.05), indicating that the overall absence of an amplitude
response was not masking a time-of-day specific amplitude
response in these tissue.
Not only amplitude, but also phase of the rhythms of tissues was
affected by medium and DEX treatment in vitro. Figure 3A shows
the phase shift response of individual atrial cultures when treated
in vitro with medium or DEX at different time intervals after the
peak in PER2LUC bioluminescence. Within 0 to 9 hours following
the peak phase of the rhythm, phase delays were observed in the
atrium, whereas 9 to 15 hours after the peak phase, shifts in the
rhythm were characterized by phase advances. Between 16 and 18
hours after the peak phase, the phase shifting responses of both
medium and DEX consist of minor variations around 0 hr, which
is typically referred to as the ‘dead zone’ of a phase response curve.
These shifts are binned in 3 hours (Figure 3B) and the absolute
magnitude of the phase shifts differs both between different times
of day and between the treatment type (two-way ANOVA, effect
of time F7,96 = 6.198, P,0.001; effect of treatment F1,96 = 5.327,
P,0.05 for treatment; non-significant interaction, F7,96 = 1.730,
P.0.05). The phase responses for DEX were different from those
of medium, and Figure 3C shows the phase responses that are
attributable to DEX through subtraction of medium induced
responses. In this format, a dead zone for DEX-specific responses
extends from between 16 and 23 hours after the peak phase.
Interestingly, there is a limited, but significant positive linear
relationship between amplitude and phase response, where a
larger amplitude increase after treatment predicts a larger absolute
phase shift (Linear regression R2= 0.14; F1, 35 = 5.6409, P,0.05).
As a reference, we also looked at the phase shift responses of
liver tissue in response to treatment with medium and DEX at
different time points centered around 6, 12, 18 and 24 hours after
the last peak in bioluminescence. The phase responses are shown
in Figure 4A and a significant effect of time of treatment and an
interaction between time*treatment was observed (two-way
ANOVA: effect of time, F3,40 = 7.419, P,0.001; effect of
treatment, F1,40 = 0.194, P.0.05; interaction effect,
F3,40 = 12.333, P,0.001). Around 6 hours after the last peak in
PER2LUC bioluminescence, the phase delay in response to
medium treatment was significantly different from that of DEX,
which caused a large phase advance (Holm-Sidak, P,0.001).
When treated 24 hours after the last peak, DEX treatment now
resulted in a large phase delay, which is significantly different from
the very small phase advance in response to medium treatment
(Holm-Sidak, P,0.005). The phase responses in the liver
(Figure 4A) were different from those observed in the atrium,
Figure 1. First peak in the bioluminescence rhythm in cultures of SCN, liver and atrial tissue of PER2LUC mice as a function if time of
culturing. Time of culturing is denoted as Zeitgeber time (ZT), where ZT0= lights on and ZT12= lights off, and the first peak as extrapolated CT
(similar as ZT, but based on the preceding light-dark cycle). Explants were cultured at ZT3.5, ZT5, ZT7 and ZT13, and all tissues examined showed an
effect of time of culturing on the subsequent in vitro phase, where culturing atrial tissue showed the strongest influence of time of culturing, with all
times of culturing resulting in a different phase in vitro. **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0047692.g001
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Figure 2. Individual baseline detrended bioluminescence recordings of per1luc and PER2LUC mice in cultures of SCN, liver and atrial
tissue. Data are explants derived from (A) per1luc and (B) PER2LUC mice. Data are plotted as smoothed data (3 hours running average, colored lines)
on top of a background of the unsmoothed data in gray tone. Grey blocks indicate time of treatment for the medium and DEX treated cultured.
Amplitude responses to medium and DEX treatment for cultures of PER2LUC mice are shown in panel C. The amplitude changes in cultures of atria are
further plotted in panel D, showing the responses at different times of day. ***P,0.001. Note the different scale on the atrial traces of per1
bioluminescence due to absence of pre-treatment rhythmicity.
doi:10.1371/journal.pone.0047692.g002
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which is replotted on the same time-scale in Figure 4B. A
significant difference in phase shifts was observed between
treatment of atrium and liver with medium and DEX (PROC
mixed: interaction effect of tissue, treatment and time
F6,144 = 4.26, P,0.001).The responses to medium treatment differ
between atria and liver when treated between 9–15 hours only
(LSmeans, t144 = 3.34, P,0.005). Contrastingly, DEX treated liver
and atria show tissue-specific responses when treated between 3–9
and 9–15 hours (LSmeans, t144 =25.49, P,0.001 and
T144 = 3.36, P,0.005 respectively, see Figure 4C).
Because the SCN has been reported to not shift in response to
DEX treatment, we included SCN cultures as a control. We
examined whether there was a phase shift in per1luc and PER2LUC
bioluminescence in response to medium and DEX treatment. Both
treatments resulted in minimal phase shifts (medium,
Table 1. The proportion and percentage occurrence of
rhythms of per1luc or PER2LUC bioluminescence observed in
cultures of SCN, liver and atrium.
per1luc PER2LUC Rhythmicity P
SCN 28/30 22/22 97% NS
Liver 36/45 83/98 82% NS
Atrium 4/45 116/118 9% vs 98% ,0.001
doi:10.1371/journal.pone.0047692.t001
Figure 3. Phase shift responses to medium and DEX treatment of cultures of atrial tissue taken from PER2LUC mice. (A) Data are
plotted as phase shifts to treatment given at different times after the last peak in bioluminescence. For statistical analysis the data were grouped in 3
hour bins (B) and there is a significant effect of treatment, where DEX treated cultures always showed a larger phase shift than medium treated
cultures. Panel C shows a DEX-only PRC, as calculated by subtracting the medium response from the DEX response as binned in panel B.
doi:10.1371/journal.pone.0047692.g003
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0.1460.81 hr; DEX, 20.0160.94 hr; mean 6 SEM) and our
data indicate that indeed there was no effect of DEX treatment, as
compared to medium treatment (two-way ANOVA: effect of time,
F3,16 = 0.156, P.0.05; effect of treatment, F1,16 = 1.417, P.0.05;
Figure S2).
The large responses to medium treatment, especially in the
cultures made from atrial tissue, were striking, and we wished to
investigate whether these responses were related to the mechanical
movement during the media change procedure and/or serum
content or change in gas pressures in the air-tissue/medium
interface. We cultured atrial tissue and removed them from the
incubator at 3.7560.28 hours (mean 6 SEM; range of 1.0–5.0
hours) after the last peak, a time at which we expect to see a
moderate phase delay in response to the media treatment. When
we did not treat the atria but simply removed the tissue from the
incubator, we observed no net phase shift, 0.1660.52 hour (mean
6 SEM), in PER2LUC bioluminescence (Figure 5). Similarly,
removing the tissue from the incubator but opening the lid of the
sealed tissue culture dish to provide for air exchange, did not result
in a phase shift comparable to that of medium treatment,
20.9060.39 hours (mean 6 SEM). When we treated the tissue
with fresh medium containing 0%, 1% or 5% serum (5% being the
standard concentration used in all other experiments) or its own
medium, we observed phase delays, and with similar magnitudes,
24.1360.04 hours (mean 6 SEM). The phase delays seen in all
four medium treatment groups was significantly different from the
limited phase response of untreated (but moved) or lid opened
atrial cultures (one-way ANOVA, F5,102 = 10.836, P,0.001). Post
hoc Holm-Sidak t-tests reveal that all four medium treatment
groups showed significant phase delay responses to media
treatment as compared to the removal from incubator only and
lid opened groups (both no medium exchanged or lid opened only
versus all media treatments, P#0.001). Interestingly, no difference
was observed in the magnitude of phase shifts between the four
different medium groups (P.0.05), suggesting that the change in
media type, namely fresh versus original media, or the presence/
concentration/absence of serum in the media, is not causative for
this phase shift response of the atria. Moreover, the absence of
phase shifts in the lid opened group also suggests that the phase
shift response is not due to partial pressure changes in O2, CO2
and H2O in the air surrounding the surface of the tissue and
culture medium.
Because of the differences observed in the atria in the
pronounced occurrence of robust rhythms in PER2 expression
but absence of per1 expression rhythms, we wished to examine this
phenomenon in another in vitro peripheral tissue system. We used
NIH3T3 fibroblast cultures to look at rhythmicity of per1 and per2
gene expression induced by serum treatment (Figure S3). Analysis
of per1 revealed an acute effect of the serum treatment (one factor
ANOVA for time= 0–48 h, F13,42 = 2.6, P,0.01; time= 0–8 h,
F3,12 = 7.1, p,0.01) with mRNA levels being induced 1h following
serum stimulation (post hoc Dunnett’s t-test, p,0.05) and then
decreasing back to non-fluctuating levels by 4 h (P,0.05). Analysis
of per2 revealed an effect of the serum treatment upon mRNA
levels (one factor ANOVA, F13,68 = 8.4, P,0.001). The levels of
per2 were induced transiently peaking 1 h following the start of the
Figure 4. Phase shift responses to medium and DEX treatment of cultures of liver tissue derived from PER2LUC mice. (A) Data are
binned in 6 hour bins centered on 6, 12, 18 and 24 hours after the last peak in bioluminescence and responses differ between medium and DEX
treated tissue, specifically for the phase responses after treatment centering around 6 and 24 hours after the last peak in the bioluminescence
rhythm. For reasons of comparison, atrial phase responses to medium and DEX treatment are re-plotted on the same time scale as the liver in panel B.
The liver and atrium show markedly different responses to treatment, and a statistical comparison between treatment and tissue is summarized in
panel C. NS = not significant, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0047692.g004
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serum treatment (post-hoc Dunnett’s t-test, p,0.05) and decreased
to baseline levels by 8 h post serum (p,0.01), then rose to peak
again 24 h later (12 h v. 24 h, p,0.01) and decrease to low levels
again by 36 h (p,0.01) rising again at 48 h. These data reveal a
significant acute induction of both per1 and per2 gene expression in
response to serum treatment, but a significant rhythm was
observed for per2 only.
We made one other observation on the peak phasing of the
PER2LUC bioluminescence rhythm in cultures made from atrial
tissue. As shown in Figure 6, the mean phase of the PER2LUC
bioluminescence in the right atrium was more than 2 hours (and 7
minutes) later than the left atrium (t-test, t35 = 4.1, P,0.001).
Discussion
In our initial in vivo approach, we discovered that time of
culturing influences post-culturing peak time of the PER2LUC
bioluminescence rhythm. This effect was strongest in atrial tissue,
but was also evident in SCN and liver tissue. It is important to note
that in the atrial tissue, phases of the PER2LUC bioluminescence
rhythm are shifted within 24-hour range when they were cultured
Figure 5. Effect of medium exchange procedure on the magnitude of phase shifts of atrial explants. Data are phase responses of
cultures of atrial tissue of PER2LUC mice to treatment with gas exchange only (tissue culture lid opened), medium exchange with different serum
concentrations (0, 1 and 5%) or removal and reapplication of own medium. Treatment time was at 3.7560.28 hours after the last peak of
bioluminescence (mean6 SEM; range 1.0–5.0 hours). Group means 6 SEM values are indicated by filled bars, and individual data points contributing
to these averages are shown as circles. **P#0.01.
doi:10.1371/journal.pone.0047692.g005
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at times with a 12 hour range. This indicates that the clock in the
atrium is not ‘simply’ reset by culturing (which would result in a 12
hour range, instead of a 24-hour range of shifts), but that the
phases found are the results of shifts in the atrial clock. That the
clock is not reset is further corroborated by the fact that the
interval between culturing and the first peak is dissimilar between
the different times of culturing. Since PER2 represents a state
variable of the clock, one might predict other clock components
would also be affected similarly, if not immediately, certainly later
[33].
Also in atrial cultures from per1:luciferase (per1:luc) rats, an effect
of time of culturing has been observed when prepared at two
different time points six hours apart [16]. The peak phase of
cultured rat per1:luc SCN tissues also shows an effect of time of
culturing, with a range of 6 hours [34], which is similar to the
range we find in the SCN in the current study in mouse PER2LUC
bioluminescence. In the same study also rat pineal and pituitary
(but not cornea) tissue peak phase in vitro exhibits modulation by
time of culturing. The susceptibility of tissue to shifting effects due
to culturing time appears to correlate with the amplitude of
oscillation, which may be indicative of oscillator stability [34]. The
large phase shifts that we see in the atrium may indicate that the
clock in the atrium is less robust than those in the liver or SCN,
but may also indicate a specific atrial sensitivity to mechanical
stress (see later).
We continued our study with an in vitro approach, and cultured
all tissues at the same time of the circadian day. An initial
observation we made was that when we culture the mouse atrium,
per1luc bioluminescence showed no significant circadian rhythm. A
30 minute DEX treatment resulted in a large peak in biolumi-
nescence, and in many cases one or more ‘cycles’ of per1luc
bioluminescence followed the DEX treatment of these atria. In
contrast, in rat in vitro cultures of atrial tissue, per1 driven
bioluminescence is reported to be rhythmic [16]. So and
colleagues [25] also report DEX induced expression of per1 and
per2 in mesenchymal stem cells in vitro, but the transcriptional levels
of per1 in untreated cells is markedly less rhythmic than per2, if
rhythmic at all, which is in line with our results. The induction of
an oscillation in constitutively expressed per1 by DEX treatment, is
in line with the notion that humeral signals phase-synchronize
individual cells within a tissue [35,36]. These data also suggest that
some of the dampening of rhythms in per1luc expression observed in
peripheral tissue explants in culture may be explained by not only
a dissociation of coordinated rhythmicity of individual cells but
also by the loss of rhythmicity within the individual cells. Since this
loss is most apparent in tissues derived from the per1:luc rat and less
obvious in the PER2::LUC mouse [21,37] would be consistent
with our data that also show a robust rhythm in atrial PER2LUC
but absence in atrial per1luc. Additionally, the per1 rhythm observed
in vivo in the heart [11–14], but which is absent in our study in vitro,
is likely to be driven by signals derived from outside of the tissue,
i.e. it is a ‘‘systematically driven gene’’ [38]. A limitation to this
interpretation is that whilst our study focused on the atria, the in
vivo studies examined tissues harvested from the ventricle or whole
heart.
Whilst the circadian clock in immortalized fibroblasts has been
shown to be synchronized by serum treatment [20,23,39], in the
current study in mouse NIH3T3 cells we observe a discrete
rhythm in per2 gene expression but the absence of a significant
rhythm in per1. This is consistent with other studies of
synchronized NIH3T3 cells that show either an absence of
significant per1 rhythmicity ([40–42]; Best, J.D., Duffield, G.E.,
Loros, J.J. and Dunlap, J.C., unpublished data) or a low
amplitude/dampening rhythm [39,43,44], whilst simultaneously
reporting discrete rhythms in other clock genes, e.g. per2, per3, cry1
and bmal1. Interestingly, this observation is consistent with the
results of our PER2LUC and per1luc analysis in cultured atria, and
provides yet more evidence for cell and tissue-dependent
organization of the clock.
We further continued to explore the PER2 expression in atrial,
liver and SCN tissue in a time informed manner. While the
amplitude of PER2 driven bioluminescence is not significantly
altered by DEX treatment in SCN and liver tissue, atrial tissue
shows an on average more than 3-fold increase in biolumines-
cence. The observation that the SCN is not responsive is in line
with the literature (see [24]). We are unaware of any reports that
report the differential amplitude response of PER2 to DEX
treatment in liver and atrium that we observe. On further analysis,
we found that the amplitude response was strongly dependent on
time of treatment. The amplitude response curve shows a maximal
Figure 6. Timing of the first peak in the bioluminescence rhythm in cultures of left and right atrium of PER2LUC mice. The phases for
individual cultures and mean 6 SEM are shown. The phase is plotted as Zeitgeber time (ZT), based on the preceding light-dark cycle, where
ZT0 = lights on and ZT12= lights off.
doi:10.1371/journal.pone.0047692.g006
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amplitude response when atrial tissue is treated with DEX around
the time of intrinsic peaking of bioluminescence, and a low to
absent amplitude response to DEX treatment is observed around
18 hours after the last peak.
Both the per1 and per2 genes contain glucocorticoid receptor
binding sequences, and for per2, these binding sequences are
essential for in vitro amplitude response to DEX in cultured
primary mesenchymal stem cells [25]. Whether the amplitude
increase in per1 in response to DEX is due to direct stimulation of
the glucocorticoid receptor binding sequences in the per1 gene, or
is the secondary results of per2 amplitude upregulation in our
tissues is unclear. It is curious to see that in the liver per1, but not
PER2 amplitude is upregulated in response to DEX treatment,
indicating tissue specific regulation of per1 and PER2 genes to
DEX, and per1 amplitude regulation independent of PER2. In in
vitro cultures of primary mesenchymal stem cells, circadian
rhythms in per2 show larger circadian amplitude in transcription,
as well as overall increased levels of transcription in response to
DEX treatment [25]. Interestingly, a restraint induced stress
response, also only upregulates per1 mRNA in the heart and liver,
and not per2 [13].
Besides amplitude responses, we also looked at phase shift
responses of PER2 reporting bioluminescence to medium and
DEX treatment. We find that cultures made of atrial tissue show
both a response to medium treatment and DEX treatment, but the
treatment with DEX is always additive, and the magnitude of the
phase response is similar to that reported for in vivo treatment of
DEX in the liver [24]. To our knowledge, this is the first report of
a time-dependent response to DEX in the atrium, or any other
tissue than the liver.
As a positive control we also looked at the PRC to DEX
treatment in the liver. We find that also the liver shows clear
responses to medium and DEX treatment, but in the liver, the
shapes of the respective phase response curves (PRCs) are much
more different than they are in the atrium. Importantly, the
direction of the phase responses (delays or advances) to DEX in
the liver in vitro are as predicted from the in vivo DEX PRC [24],
assuming that the peak phase of PER2 represents ,CT18–19
[45]. In comparison to the atrial PRC to DEX treatment, the liver
shows a significantly different type and size of response to DEX
treatment. We also used the SCN as a negative control and as
predicted this tissue exhibited limited responses to DEX treatment.
Interestingly, our data indicates the presence of a ‘dead zone’ in
atrial phase responses to DEX, in which the stimulus does not
result in a shift of the rhythm [24]; between 16–23 hours and 16–
18 hours after the last peak in bioluminescence the observed DEX
phase responses consist of minor variations around 0 hrs (with and
without medium responses subtracted, respectively). This is in
contrast to the liver, where the PRC for DEX treatment in vivo
indicates the absence of such a large ‘dead zone’ [24]. However,
our in vitro liver data does in fact show limited DEX induced phase
shifts at 12.5–13.5 hours after the last peak in bioluminescence,
suggesting the presence of an unresponsive component of the liver
DEX PRC.
Medium treatment appears to have a smaller effect in the liver
than in the atrium. In the atrium, where the medium treated PRC
is relatively large and shows both advances and delays, the
medium treated PRC may be have been due to the serum in the
medium. However, we found no significant difference in response
between 0, 1 and 5% serum in the fresh medium or treating with
its own original medium. Also, the similar response to fresh
medium and treatment with its own medium indicated that the
response is not elicited by a factor that is present in the new
medium. Only taking the culture out of the incubator does not
result in a similar phase shift response, and opening the lid of the
culture dish also does not result in a significant phase shift,
suggesting that simply moving the culture, or gas exchange with
the external environment is not the cause of the phase shift. Taken
together, our results may suggest that some component of the
medium treatment procedure, irrespective of the content, causes
large shifts in the atrium. One explanation could be that the
atrium has a high sensitivity for the mechanical stress it undergoes
during the treatment. Such a hypothesis is intriguing, when taking
into account the mechanical nature of cardiac tissue and the
sensitivity of the atrial cardiomyocytes to stretch, and should be
studied further. This hypothesis can also be adopted to explain the
effects of timing of culturing (a mechanically stressful procedure),
which also results in a larger range of phase shifts in the atrium, as
compared to liver and SCN tissue. It may have some functional
consequence in the intact animal with clock resetting of the heart,
noting that day versus night differences in activity of the heart
occur and are often associated with daily temporal exposure to
exercise and stress. Furthermore, several components of the
intracellular signaling cascade responsible for conveying the atrial
myocardial stretch response for atrial natriuretic peptide secretion,
are shared with those regulating the circadian clock, e.g. protein
kinase C and mitogen-activated protein kinase (MAPK)
[22,32,46–48].
Both the per1 and per2 genes contain glucocorticoid receptor
binding sequences, making direct interaction between the gluco-
corticoid receptor and each gene promoter possible, and may be
indicative that per1 and per2 are sites of action for DEX to alter the
circadian clock [25]. Using liver specific knockout of the mouse
circadian clock, Kornmann et al [38,49] revealed that rhythmic
expression of per2 in the liver, is under the control of both the local
clock and systemic cues. This makes per2 an ideal candidate gene
for an ‘entry point’ of systemic cues into the local liver clock. Our
data indicate that indeed PER2 expression is altered in response to
DEX in terms of phase in both the atrium and the liver, while per1
does not show rhythmic expression in the atrium in the absence of
external signals. In contrast, per1 appears to be the more
responsive of the two genes to DEX in both liver and atrium in
terms of amplitude, while PER2 only shows an amplitude response
in the atrium.
In the data presented here, we observe tissue dependent
differences in per1 and PER2 reported bioluminescence: 1) per1 is
not rhythmic in atria, while PER2 is rhythmic; 2) Amplitude
responses in PER2 to DEX treatment are absent in liver and SCN,
but show a clear time-dependent response in the atrium; 3) The
PER2 phase response curve to DEX treatment in the atrium is
significantly different from the liver. In addition there is a gene
related observation, which is that we observe an amplitude
response to DEX treatment in per1, but not PER2 in the liver,
while in the atrium both per1 and PER2 respond to DEX
treatment with an amplitude increase. These tissue dependent
observations are in line with the finding of tissue-dependent effects
of per2 and per3 knockout mice [50]. Conversely, it has been shown
that blood-borne cues can elicit circadian rhythm in liver and
kidneys of animals bearing SCN lesions, but not in heart, spleen,
or skeletal muscle of the same animals [51]. These data highlight
the diversity and complexity of the local tissue circadian clocks.
As a last observation, we noticed a significant phase difference
between the PER2 reporting bioluminescence peaks, where the
right atrium is significantly delayed as compared the left atrium. In
an earlier study by Davidson et al [16] cultures of the left ventricle
appeared to have a delayed phase compared to those of the right
atrium in per1-driven bioluminescence in the rat. This finding may
indicate that the functional differences in the left and right atria
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and ventricles is reflected in phase angle differences between the
clocks in these cardiac compartments.
The physiological relevance of our findings are several: firstly,
the GR specific effect on atrial amplitude of canonical clock
components would ensure a robust pacemaker, achieved either
through individual cell changes in amplitude, or through increased
coordinated rhythms in expression in a population of cells, or a
combination of the two (see above). In vivo, normal GR signaling
on a daily basis may be an important mechanism in the cardiac
system for maintaining normal cardiomyocyte 24 hr rhythmicity.
Secondly, whilst the phase resetting effect of GR signalling in the
circadian clock has been demonstrated [22], little is known of this
mechanism of entrainment beyond the hepatic system. Differences
in the phase response curves to DEX between atria (heart) and
liver may explain the phase differences in rhythms of certain
canonical clock genes observed in vivo between these two tissues
[11]. For example, inspection of the phase estimate data in this
study [11] reveal per1 and per2 to peak at earlier circadian times in
the heart compared to the liver, with a phase difference of
approximately 3 hours. Thirdly, the implications of our data are
implicit if we consider that DEX and other glucocorticoid drugs
are used in the broad treatment of inflammatory and autoimmune
conditions [52,53]: the effects of such treatment paradigms could
alter internal circadian coordination between different organ
systems and between the heart and the day-night/activity-rest
cycle, and therefore might impact cardiovascular health. Fourthly,
the apparent sensitivity to mechanical change highlights the
possibility that enhanced cardiac activity in vivo, such as during
exercise or stress, might in itself result in a resetting of the
circadian clock of the atria.
In summary, we find that the clock in atrial tissue shows a strong
phase shifting effect in response to time of culturing. Together with
the phase shift observed after medium treatment, this could lead to
the hypothesis of a time-dependent sensitivity of the atrial clock to
mechanical treatment, which is highly relevant for a tissue that
shows a daily variation in mechanical (stretch and contractile)
activity. Atrial tissue also shows phase shifting responses to DEX,
which is markedly different from that of the liver. Moreover, in
atrial tissue per1luc expression is not rhythmic, but can be induced
by DEX, while PER2LUC is rhythmic and shows a strong
amplitude response at certain times within the circadian cycle.
To our knowledge, this is the first report of a time dependent
response to DEX in the atrium, or any tissue other than the liver.
These data indicate that the clock in the atrium has a defined
glucocorticoid sensitivity and circadian clock characteristics in vitro.
Materials and Methods
Ethics Statement
Animal experiments were approved by the University of Notre
Dame Animal Care and Use Committee (protocol number 14–
080) and performed in accordance with NIH Guidelines for the
Care and Use of Laboratory Animals.
Animals
Adult (age = 276624 days, mean 6 SEM) per1:luciferase (per1luc;
N= 11; CD1 background; [54]) and PER2::LUCIFERASE
(PER2LUC; N= 13; C57bl/6J background; [37]) mice were
generated from in-house breeding at the University of Notre
Dame. Food and water were available ad libitum. Animals were
housed in 12 h light:12 h dark (LD) regimen under climate
controlled conditions (19–21uC, 60–70% humidity). All mice were
entrained to the LD regimen for at least 3 weeks, allowing all
tissues to be stably entrained at the time of tissue culturing.
Culturing and Treatment
Mice were sacrificed by cervical dislocation at 2–4 hours into
the light period of the LD cycle (ZT 2–4; ZT 0= lights on, ZT
12= lights off). Brain, heart and liver tissue was quickly removed
and placed in ice-cold Hanks Balanced Salt Solution (HBSS;
Cellgro, Mediatech, Inc., VA, USA). Coronal sections of the brain
(300 mm thickness) were cut on a manual vibroslice (NVSL; World
Precision Instruments, Inc., FL, USA). Brain regions were
identified under a dissecting microscope and the SCN was isolated
as a square tissue (,1.5 mm2), containing either a rostral or caudal
aspect of the SCN. Liver tissue was also sectioned using the
vibroslice at a thickness of 250 mm, and isolated in a square of
approximately 1 mm2. Left and right atrial tissue was hand-cut
with scalpel blades and reduced to small cubes (,1 mm3), and in
all experiments explants were taken from both right and left atria.
We cultured only atrial, and not ventricular tissue, because we
were unable to consistently generate ventricle explants that
exhibited reliable rhythms in gene/protein expression.
Explants were cultured, using an established method, on a
polypropylene mesh or permeable membrane, creating an
interface between culture medium and humidified air and housed
within sealed culture dishes [55–57]. SCN tissues were cultured on
culture plate inserts (Millicell, Millipore, MA, USA), and atria and
liver were placed on a mesh (Polypropelyne Spectra/Mesh
[210 mm opening, 308 mm thickness, 34% open area], Spectrum
laboratories,Inc., CA, USA). All tissue samples were placed in
individual 35 mm translucent petri dishes with 1.2 ml of culture
media composed of Dulbecco’s Modified Eagle’s Medium (Sigma-
Aldrich), 19 mM D-glucose, 4.2 mM NaHCO3, 10 mM HEPES,
25 U/ml penicillin and streptomycin, 5% FBS and 100 mM
luciferin (Luck-100, Gold Biotechnology, MO, USA), and sealed
with vacuum grease and glass coverslips [57]. Tissues were placed
in a light tight box at 36uC and bioluminescence was measured
using a photomultiplier tube (LumiCycle, ActiMetrics, IL, USA)
every 10 min.
As a reference, Table 1 and Figure 1 report on success rate of
culturing and effects of time of culturing on the occurrence of the
first peak in the rhythm. The analysis presented in this table and
figure are based on all experiments conducted in our laboratory
including the two mouse lines that are also used in the experiments
reported here.
For treatment, samples were taken out of the incubator, but
remained in the petri-dishes and were kept at a constant
temperature of 37uC on a slide warmer during the media
changing process. The culturing medium was aspirated off and
kept in the dark at 37uC, to be returned after treatment. Tissues
were given fresh culture medium, with or without 100 nM
dexamethasone (DEX: Dexamethasone 21-phosphate disodium
salt, Sigma-Aldrich, MO, USA) [24], without luciferin, for 30 min.
During the incubation, samples were maintained in an incubator
at 37uC. Subsequently, cultures were washed twice with 37uC
culture media without luciferin each for 3–5 min and the original
medium was returned. All tissues were subsequently placed back
into the LumiCycle, for continued bioluminescence measure-
ments.
Experimental Design and Analysis
Our primary interest lay with atrial responses to DEX. As a
reference SCN tissue was cultured as a tissue that does not respond
to DEX, and the liver, as a tissue with some reported responses to
DEX. Tissue cultures from both per1luc and PER2LUC mice
were submitted to one of three experimental groups: no treatment,
medium treated and DEX treated tissues. Tissues were treated at
different times during the circadian cycle, and timing of the
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treatment was denoted as time since the last peak in biolumines-
cence driven by either per1 or PER2. The effect of treatment was
assessed both for amplitude responses and phase changes of the
bioluminescent signal. Amplitude changes in per1luc and
PER2LUC reporting tissues were expressed as the ratio between
the bioluminescence counts of the last pre-treatment peak to the
first post-treatment peak. Phase changes in PER2LUC reporting
tissues were calculated for medium and DEX treated cultures by
comparing the first post-treatment peak in bioluminescence to that
of the phase-matched no treatment control. Using this method, we
controlled for possible variations in initial phase after the culturing
procedure, e.g. due to culturing an explant derived from left or
right atrium. In an additional experiment, we tested the magnitude
of the phase shift of atrial tissues in response to an exchange in
own culture medium and to exposure to fresh media of varying
concentrations of 0, 1 and 5% fetal bovine serum versus only
removal of the culture from the incubator. So as to mimic our
basic medium/DEX protocol, in each case where medium was
exchanged, cultures were washed twice with 37uC culture media
without luciferin each for 5 min and the original medium was
returned. To control for partial pressure changes in O2, CO2 and
H2O in the air surrounding the surface of the tissue and culture
medium, in a separate group lids were removed for 2 min to
provide for air exchange, but otherwise the medium and explant in
the culture dish were not disturbed.
Peak/trough Determination
Recorded bioluminescence data were baseline subtracted (24
hour boxcar smoothing) and peaks and troughs were determined
using an in-house algorithm detecting inflection points, described
as follows. A low-pass filter was applied through boxcar smoothing
on a 3 hour window size, thus removing small fluctuations outside
the circadian range. A sliding set of two adjacent groups of 18 data
points (representing 3 hours) was iteratively run through the
dataset, moving forward one data point at a time. Forced linear
regressions were calculated through each of the two groups of 18
data points and compared for the sign of the slope. An inflection
point was called when the sign of the slope switched - with a
‘stability prerequisite’ that the slopes found in the preceding and
following iteration did not show a sign change. A personal
computer (PC) tool running this algorithm is available upon
request.
Northern Blot Analysis of Gene Expression in Mouse
NIH3T3 Fibroblasts
Mouse NIH3T3 fibroblasts (ATCC) were grown in DMEM,
10% fetal calf serum and PSG at 37uc in 5% C02, and seeded as
2.56105 cells/10 cm. Cells reached confluency after 4 days. After
7 days, cells were treated with 50% horse serum medium (in
DMEM+PSG) for 2 hours, which was replaced with serum free
DMEM+PSG for the duration of the experiment. The cells were
taken at time= 0, 1 and every 4 hours for a 48 hour period (start of
serum treatment was designated time= 0 h), rinsed with 1X PBS
and total RNA harvested in 1 ml of Trizol (Gibco BRL) and
purified following the Gibco BRL protocol. 20–40 mg of RNA was
obtained per petri dish.
For Northern blot analysis, 10 mg of the extracted total RNA
were electrophoresed on a 1% agarose gel containing 5%
formaldehyde, and RNAs transferred to nitrocellulose membrane
(Osmionics, Westborough, MA) by capillary transfer. For ribop-
robes the following templates were used: mPer1, 627–1681 (ORF);
mPer2, 768–1643 (ORF); Riboprobes were synthesized using
plasmids transcribed into antisense RNA riboprobes using Strip-
EZ RNA kit (Ambion, Austin, TX) with T7 polymerase and NEN
[alpha-32P] dUTP (6000 Ci/mmol) to a specific activity of
109 cpm/mg. Hybridization was carried out at 60–65uC, and
blots washed according to standard techniques [23] and exposed
to Kodak X-Omat Blue XB-1 film for 1–3 days. Densitometric
determinations were made using Adobe PhotoShop after scanning
films. Northern blot signals were normalized to ethidium bromide
stained 28 S ribosomal band signals on the membrane. mRNA
values were made relative the median mRNA value of the
individual time course (1.0).
Statistics
A comparison of the number of cultures that were deemed
rhythmic or not rhythmic between per1luc and PER2LUC was tested
using a chi-square contingency table. Northern blot signals over
the 48 h time courses were analyzed by one-factor ANOVA,
followed by post-hoc Dunnett’s t-tests. Amplitude and phase shift
measures in response to treatment were tested using ANOVA’s
with levels time, tissue and treatment where applicable. Post hoc
analysis of significant main and interaction effects was conducted
using the Holm-Sidak multiple pairwise comparisons test. Due to
the non-equidistant nature of the data, phase shifts were averaged
per 3 hours (atrium) and 6 hours (liver) for statistical analysis. A
comparison between atrial and liver responses to medium and
DEX treatment at different time of day was made by fitting a
mixed linear model to the data (SAS, proc mixed). The timing of
the amplitude responses to DEX in PER2LUC bioluminescence
was also tested by fitting a mixed linear model to the data (proc
mixed) and phase differences between right and left atrium were
tested using a Student’s t-test. All analyses were conducted using
SAS version 9.2 (SAS Institute, Cary, NC, USA) or Sigmaplot
version 11 (Systat Software, Inc., Chicago, IL, USA).
Supporting Information
Figure S1 Amplitude responses to medium and DEX
treatment for cultures of per1luc mice. Similar to PER2LUC
mice, per1luc SCN tissue did not show a change in amplitude in
response to treatment. In contrast to PER2LUC mice, per1luc liver
tissue exhibited an increased amplitude after medium treatment,
and a further increased amplitude after DEX treatment. Atrial
tissue did not show a pre-treatment rhythm in bioluminescence,
and therefore the increase in bioluminescence after treatment (see
Figure 2) could not be quantified. N/A=not available, none=not
treatment. **P,0.01.
(PDF)
Figure S2 Phase shift responses to medium and DEX
treatment of cultures of SCN tissue of per1luc and
PER2LUC mice.
(PDF)
Figure S3 per1 and per2 gene expression profiles in
serum-stimulated mouse NIH3T3 fibroblasts. (A) Repre-
sentative Northern blots showing transcriptional profiles. Band
sizes described at right in kilobases (kb). Mean6 SEM time course
profiles for per1 (B) and per2 (C) gene expression. Data are
represented as fraction of median expression (1.0) and values are
plotted as mean 6 SEM (N=4–7 Northern blots). Both per1 and
per2 were induced with 1 hour after serum treatment (one-way
ANOVA, P,0.01 and P,0.001 for per1 and per2 respectively).
After 8 hours per1 levels were back at baseline and remained there,
while in per2 a circadian oscillation was induced, and mRNA levels
peaked again 24 h and 48 h later (Dunnett’s t-tests; P’s ,0.05 at
least).
(TIFF)
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